Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 8/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.37 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11508215 | 0.80 | ALDH1A1 (0.36) | SIGMAR1CYP2D6ALDH1A1KDM4EGAA | |
| SCHEMBL1486294 | 0.80 | SIGMAR1 (0.53) | SIGMAR1CYP1A2CYP2D6CYP2C19ALDH1A1 | |
| SCHEMBL10465512 | 0.80 | SIGMAR1 (0.53) | SIGMAR1CYP1A2CYP2D6CYP2C19ALDH1A1 | |
| SCHEMBL7411647 | 0.77 | SIGMAR1 (0.49) | SIGMAR1CYP1A2CYP2D6CYP2C19ALDH1A1 | |
| Nitrogen SCHEMBL27346241 | 0.77 | SIGMAR1 (0.59) | SIGMAR1CYP1A2CYP2D6CYP2C19ALDH1A1 | |
| SCHEMBL1683320 | 0.76 | SIGMAR1 (0.63) | SIGMAR1CYP1A2CYP2D6CYP2C19ALDH1A1 | |
| SCHEMBL29364795 | 0.76 | SIGMAR1 (0.63) | SIGMAR1CYP1A2CYP2D6CYP2C19ALDH1A1 | |
| SCHEMBL27737084 | 0.76 | SIGMAR1 (0.63) | SIGMAR1CYP1A2CYP2D6CYP2C19ALDH1A1 | |
| SCHEMBL29555314 | 0.76 | SIGMAR1 (0.63) | SIGMAR1CYP1A2CYP2D6CYP2C19ALDH1A1 | |
| SCHEMBL2349 | 0.76 | SIGMAR1 (0.63) | SIGMAR1CYP1A2CYP2D6CYP2C19ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0517852-B1 | TRI- AND TETRA-SUBSTITUTED GUANIDINES AND THEIR USE AS EXCITATORY AMINO ACID ANTAGONISTS | OREGON STATE (US) | 2002-07-10 | — | — | EP | disclosed |
| US-6251948-B1 | Tri-and tetra-substituted guanidines and their use as excitatory amino acid antagonists | STATE OF OREGON, ACTING BY AND THROUGH THE OREGON STATE BOARD OF HIGHER EDUCATION, ACTING FOR AND ON BEHALF OF THE OREGON HEALTH SCIENCES UNIVERSITY AND THE UNIVERSITY OF OREGON | 2001-06-26 | — | — | US | disclosed |
| US-5798390-A | Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists | STATE OF OREGON, ACTING BY AND THROUGH THE OREGON STATE BOARD OF HIGHER EDUCATION, ACTING FOR AND ON BEHALF OF THE OREGON HEALTH SCIENCES UNIVERSITY AND THE UNIVERSITY OF OREGON (US) | 1998-08-25 | — | — | US | disclosed |
| US-5767162-A | NERVOUS SYSTEM DISORDERS, BRAIN DISORDERS | STATE OF OREGON, ACTING BY AND THROUGH THE OREGON STATE BOARD OF HIGHER EDUCATION, ACTING FOR AND ON BEHALF OF THE OREGON HEALTH SCIENCES UNIVERSITY AND THE UNIVERSITY OF OREGON (US) | 1998-06-16 | — | — | US | disclosed |
| US-5637622-A | NERVOUS SYSTEM DISORDERS | STATE OF OREGON, ACTING BY AND THROUGH THE OREGON STATE BOARD OF HIGHER EDUCATION, ACTING FOR AND ON BEHALF OF THE OREGON HEALTH SCIENCES UNIVERSITY AND THE UNIVERSITY OF OREGON (US) | 1997-06-10 | — | — | US | disclosed |
| US-5559154-A | Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists | OREGON STATE BOARD OF HIGHER EDUCATION | 1996-09-24 | — | — | US | disclosed |
| US-5489709-A | REACTING MONO-SUBSTITUTEED CYANAMIDE WITH A SECONDARY AMINE | CAMBRIDGE NEUROSCIENCE, INC. | 1996-02-06 | — | — | US | disclosed |
| EP-0634997-A4 | PREPARATION OF SUBSTITUTED GUANIDINES. | CAMBRIDGE NEUROSCIENCE RES (US) | 1995-04-26 | — | — | EP | disclosed |
| EP-0634997-A1 | PREPARATION OF SUBSTITUTED GUANIDINES | CAMBRIDGE NEUROSCIENCE RESEARCH, INC. (US) | 1995-01-25 | — | — | EP | disclosed |
| US-5336689-A | Treating diseases of the nervous system; neuroprotective | STATE OF OREGON, ACTING BY AND THROUGH THE OREGON STATE BOARD OF HIGHER EDUCATION, ACTING FOR AND ON BEHALF OF THE OREGON HEALTH SCIENCES UNIVERSITY AND THE UNIVERSITY OF OREGON (US) | 1994-08-09 | — | — | US | disclosed |
| US-5298657-A | From a cyanamide and an amine, Lewis acid catalyst | CAMBRIDGE NEUROSCIENCE INC. (US) | 1994-03-29 | — | — | US | disclosed |
| EP-0517852-A4 | — | — | 1994-03-02 | — | — | EP | disclosed |
| US-5262568-A | Neuroprotective compounds, high binding affinity for phencyclidine, nervous system disorders | STATE OF OREGON (US) | 1993-11-16 | — | — | US | disclosed |
| WO-1993019042-A1 | PREPARATION OF SUBSTITUTED GUANIDINES | CAMBRIDGE NEUROSCIENCE, INC. (US) | 1993-09-30 | — | — | WO | disclosed |
| EP-0517852-A1 | TRI- AND TETRA-SUBSTITUTED GUANIDINES AND THEIR USE AS EXCITATORY AMINO ACID ANTAGONISTS | STATE OF OREGON, acting through OREGON STATE BOARD OF HIGHER EDUCATION, acting for OREGON HEALTH SC. UNIV. AND UNIV. OF OREGON (US) | 1992-12-16 | — | — | EP | disclosed |
| WO-1991012797-A1 | TRI- AND TETRA-SUBSTITUTED GUANIDINES AND THEIR USE AS EXCITATORY AMINO ACID ANTAGONISTS | STATE OF OREGON, acting by and through THE OREGON STATE BOARD OF HIGHER EDUCATION, acting for and on behalf of THE OREGON HEALF SCIENCES UNIVERSITY (US) | 1991-09-05 | — | — | WO | disclosed |